Guanfacine 70436-0041-01
- Manufacturer
- Slate Run Pharmaceuticals, Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA213428
Need to source Guanfacine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guanfacine Hydrochloride | 3 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
70436-0041-01Selected100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-041-01)